Ocular myasthenia gravis management

Authors

Mark J. Kupersmith, Department of Ophthalmology, Icahn School of Medicine at Mount Sinai, New York Eye and Ear Infirmary and Union Square Eye Care, New York, NY, United States.
Gil I. Wolfe, Department of Neurology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo/SUNY, Buffalo, NY, United States.
Henry Kaminski, Department of Neurology and Rehabilitation Medicine, George Washington University, Washington, DC, United States.

Document Type

Journal Article

Publication Date

1-1-2025

Journal

Frontiers in neurology

Volume

16

DOI

10.3389/fneur.2025.1678151

Keywords

OMG; OMG mimics; myasthenia gravis diagnosis; myasthenia gravis treatment; ocular myasthenia gravis

Abstract

Ocular myasthenia gravis (OMG) has no agreed-upon diagnostic and management criteria, leading to misdiagnoses and often misguided treatments. The purpose of this minireview is to provide guidance to clinicians who encounter possible OMG patients. We cite relevant literature and the recommendations for diagnosis and therapy based on the authors' extensive experience in OMG. This report provides sound recommendations based on the authors' successes and failures, coupled with relevant literature in the myasthenia gravis field.

APA Citation

Kupersmith, Mark J.; Wolfe, Gil I.; and Kaminski, Henry, "Ocular myasthenia gravis management" (2025). GW Authored Works. Paper 8149.
https://hsrc.himmelfarb.gwu.edu/gwhpubs/8149

Department

Neurology